Cargando…

11 ESMO 2021 breakthroughs: practicing oncologist’s perceptions on data presentation

BACKGROUND: The European Society for Medical Oncology (ESMO) 2021 conference provided a high number of randomized phase III trial reports, many of which were claimed to be practice changing. Given the short time available for conference presentations, results and conclusions tend to have greatest pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Halteren, H.K., Tan, A., Pellegrino, B., Brasiuniene, B., Bennouna, J., Cunquero-Tomás, A.J., Strijbos, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783088/ https://www.ncbi.nlm.nih.gov/pubmed/35051788 http://dx.doi.org/10.1016/j.esmoop.2021.100376

Ejemplares similares

Twelve ESMO Congress 2022 breakthroughs: practicing oncologists’ perceptions and potential application on presented data
por: van Halteren, H.K., et al.
Publicado: (2023)

Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)
por: Morgan, Gilberto, et al.
Publicado: (2016)

From ESMO TAT 2021
por: Killock, David
Publicado: (2021)

From the ESMO Congress 2021
por: Sidaway, Peter
Publicado: (2021)

Nachwuchsförderung durch die European Society for Medical Oncology (ESMO): Erfahrungen aus dem ESMO Young Oncologist Committee (YOC)
por: Oing, Christoph, et al.
Publicado: (2020)

ESMO 2021—highlights in colorectal cancer
por: Weiss, Lukas
Publicado: (2022)

Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey
por: Banerjee, Susana, et al.
Publicado: (2018)

Challenge of implementing clinical practice guidelines. Getting ESMO’s guidelines even closer to the bedside: introducing the ESMO Practising Oncologists’ checklists and knowledge and practice questions
por: Rauh, Stefan, et al.
Publicado: (2018)

Evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for adjuvant radiotherapy in breast cancer
por: Sapir, E., et al.
Publicado: (2023)

Tobacco cessation and the role of ESMO and medical oncologists: addressing the specific needs of cancer patients in times of the COVID-19 pandemic
por: Krech, R., et al.
Publicado: (2023)

EHA evaluation of the ESMO—Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies
por: Kiesewetter, Barbara, et al.
Publicado: (2020)

ESMO 2021—my top three abstracts in breast cancer
por: Suppan, Christoph
Publicado: (2022)

Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey
por: Garrido, P., et al.
Publicado: (2021)

Patient and Healthcare Professional Perspectives from ESMO 2021 on Bladder and Kidney Cancer: A Podcast
por: Filicevas, Alex, et al.
Publicado: (2022)

ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group’s perspective
por: Koessler, T., et al.
Publicado: (2022)

Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) version 1.1
por: Pichler, M., et al.
Publicado: (2021)

From ESMO 2022
por: Romero, Diana
Publicado: (2022)

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring
por: Gyawali, B., et al.
Publicado: (2021)

Corrigendum to ‘Remembering Professor José Baselga’: [ESMO Open Volume 6, Issue 3, June 2021, 100121]
por: Tabernero, J.
Publicado: (2021)

Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules
por: Dafni, Urania, et al.
Publicado: (2017)

Effect of Terminology Used to Describe Medical Oncologists on Perceptions of Radiation Oncologists as Equal Partners in Cancer Care
por: Mattes, Malcolm D., et al.
Publicado: (2020)

ESMO pays tribute to Professor José Baselga
por: Peters, S., et al.
Publicado: (2021)

ESMO pays tribute to Professor José Baselga
por: Peters, S., et al.
Publicado: (2021)

My personal highlights of ESMO 2016
por: Dediu, M., et al.
Publicado: (2017)

Patterns of practice in palliative radiotherapy for bleeding tumours in the Netherlands; a survey study among radiation oncologists
por: Strijbos, Jennifer, et al.
Publicado: (2019)

COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE)
por: Castelo-Branco, L., et al.
Publicado: (2022)

Abstracts of the 2021 Canadian Association of Medical Oncologists Annual Meeting
por: Loree, Jonathan, et al.
Publicado: (2021)

1567MO COVID-19 and cancer: First report of the ESMO international, registry-based, cohort study (ESMO CoCARE)
por: Romano, E., et al.
Publicado: (2021)

Training Camp–Presentation 11: Breakthrough -Championship Living in a Computer Age
por: Byrne, Richard B.
Publicado: (2022)

Corrigendum to ‘How I treat medullary thyroid cancer’: [ESMO Open Volume 6, Issue 3, June 2021, 100183]
por: Kiesewetter, B., et al.
Publicado: (2022)

ESMO 2017—my personal highlights
por: Kiesewetter, Barbara, et al.
Publicado: (2018)

Pain workshop ESMO: Africa (response)
por: Grant, Liz, et al.
Publicado: (2020)

ESMO 2020: highlights in breast cancer
por: Bartsch, Rupert
Publicado: (2021)

ESMO Designated Centres of Integrated Oncology and Palliative Care (ESMO DCs): education, research and programme development survey
por: Kreye, G., et al.
Publicado: (2022)

Impact of COVID-19 on social media as perceived by the oncology community: results from a survey in collaboration with the European Society for Medical Oncology (ESMO) and the OncoAlert Network
por: Morgan, G., et al.
Publicado: (2021)

Community oncologists’ perceptions and utilization of large-panel genomic tumor testing
por: Anderson, Eric C., et al.
Publicado: (2021)

AIOM chooses ESMO Open—Cancer Horizons as its official journal: a warm welcome from ESMO Open
por: Zielinski, Christoph C, et al.
Publicado: (2016)

PB2707: ESMO-MAGNITUDE OF CLINICAL BENEFIT SCALE FOR HAEMATOLOGICAL MALIGNANCIES (ESMO-MCBS:H) VERSION 1.0
por: Kiesewetter, Barbara, et al.
Publicado: (2023)

Perceptions of homeopathy in supportive cancer care among oncologists and general practitioners in France
por: Bagot, J. L., et al.
Publicado: (2021)

Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies
por: Paluch-Shimon, Shani, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oltkabt5qavb7hnn5ujlpjb5a0